Follow-up monitoring of patients with gastritis and duodenitis by a primary care physician. Guidelines

These guidelines describe the management of follow-up monitoring of patients with gastritis and duodenitis. They include the approximate scope and frequency of paraclinical investigations, as well as information on the diagnosis, treatment, and prevention of complications.

The guidelines are intended for general practitioners, family doctors, as well as for mid-level health providers working with the above-mentioned doctors, for paramedics performing the doctor functions. These guidelines can be used by healthcare executives, heads of primary care facilities, and their departments.

1. Ivashkin VT, Maev IV, Lapina TL, et al. Clinical Recommendations of Russian Gastroenterological Association and RENDO Endoscopic Society on Diagnosis and Treatment of Gastritis and Duodenitis. Russian Journal of Gastroenterology, Hepatology, Coloproctology. 2021;31(4):70-99. (In Russ.) doi:10.22416/1382-4376-2021-31-4-70-99.

2. Livzan MA, Bordin DS, Gaus OV, et al. Classification of chronic gastritis: historical background and current state of the issue. Therapeutic Archive. 2024;96(2):153- 8. (In Russ.) doi:10.26442/00403660.2024.02.202578.

3. Kusters JG, van Vliet AH, Kuipers EJ. Pathogenesis of Helicobacter pylori infection. ClinMicrobiolRev. 2006;19(3):449-90. doi:10.1128/CMR.00054-05.

4. El-Omar EM, Carrington M, Chow WH, et al. Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature. 2000;404(6776):398-402. doi:10.1038/35006081.

5. Malfertheiner P, Megraud F, Rokkas T, et al.; European Helicobacter and Microbiota Study group. Management of Helicobacter pylori infection: the Maastricht VI/Florence consensus report. Gut. 2022:gutjnl-2022-327745. doi:10.1136/gutjnl-2022-327745.

6. Sugano K, Tack J, Kuipers EJ, et al. Kyoto global consensus report on Helicobacter pylorigastritis Gut. 2015;64:1353-67. doi:10.1136/gutjnl-2015-309252.

7. Ivashkin VT, Maev IV, Kaprin AD, et al. Early detection of oncological diseases of the digestive system (methodological guidelines of the Russian Gastroenterological Association and the Association of Oncologists of Russia for primary care physicians). Russian Journal of Gastroenterology, Hepatology, and Coloproctology. 2019;29(5):53-74. (In Russ.) doi:10.22416/1382-4376-2019-29-5-53-74.

8. Ivashkin VT, Lapina TL, Maev IV, et al. Clinical recommendations of the Russian Gastroenterological Association, the Scientific Community for the Promotion of the Clinical Study of the Human Microbiome, the Russian Society for the Prevention of Noncommunicable Diseases, the Interregional Association for Clinical Microbiology and Antimicrobial Chemotherapy for the diagnosis and treatment of H. pylori in adults. Russian Journal of Gastroenterology, Hepatology, and Coloproctology. 2022;32(6):72-93. (In Russ.) doi:10.22416/1382-4376-2022-32-6-72-93.

9. German SV, Zykova IE, Modestova AV, Ermakov NV. The prevalence of H. pylori infection among the population of Moscow. Russian Journal of Gastroenterology, Hepatology, and Coloproctology. 2010;20(2):25-30. (In Russ.)

10. Rakhmanin YuA, Zykova IE, Fedichkina TP, et al. The study of the territorial distribution of Helicobacter pylori infection in the able-bodied population of Moscow during the medical examination of industrial contingents. Hygiene and sanitation. 2013;92(5):79-82. (In Russ.)

11. Svarval AV, Ferman RS, Zhebrun AB. The study of the dynamics of the prevalence of infection caused by Helicobacter pylori among various age groups of the population of St.Petersburg in 2007-2011. Infection and immunity. 2012;2(4):741- 6. (In Russ.)

12. Reshetnikov OV, Kurilovich SA, Krotov SA, Krotova VA. Helicobacter infection in Siberian populations. Byul. SORAMN. 2010;30(2):88-93. (In Russ.) Решетников О.В., Курилович С.А., Кротов С.А., Кротова В.А. Хеликобактерная инфекция в сибирских популяциях. Бюл. СОРАМН. 2010;30(2):88-93.

13. Tsukanov VV, Tretyakova OV, Amelchugova OS, et al. The prevalence of atrophic gastritis of the stomach body in the population of Krasnoyarsk over 45 years of age. Russian Journal of Gastroenterology, Hepatology, and Coloproctology. 2012;22(4):27-31. (In Russ.)

14. Bordin DS, Kuznetsova ES, Stauver EE. The prevalence of Helicobacter pylori infection in various diseases and in cohort studies conducted in the Russian Federation from 1990 to 2023: a systematic review. Effective pharmacotherapy. 2024;20(30):24-33. (In Russ.) doi:10.33978/2307-3586-2024-20-30-24-33.

15. Bordin DS, Mozgovoy SI, Livzan MA, et al. Interdisciplinary consensus Re.Ga.IN.: What's new? Part 1: Definitions, Helicobacter pylori-associated and autoimmune gastritis. Effective pharmacotherapy. 2024;20(2):54-70. (In Russ.) doi:10.33978/2307-3586-2024-20-2-54-70.

16. Drapkina OM, Kashin SV, Kuvaev RO, et al. A modern algorithm for the diagnosis and management of patients with chronic atrophic gastritis and intestinal metaplasia of the stomach. Preventive medicine. 2023;26(1):7-10. (In Russ.) doi:10.17116/profmed2023260117.

17. Drapkina OM, Ivashkin VT, Maev IV, et al. Follow-up of patients with peptic ulcer of the stomach and duodenum by a general practitioner in primary health care. Methodological recommendations. Primary health care. 2025;2(2):1-35. (In Russ.)

18. Simanenkov VI, Maev IV, Tkacheva ON, et al. Syndrome of increased epithelial permeability in clinical practice. Multidisciplinary national Consensus. Cardiovascular Therapy and Prevention. 2021;20(1):2758. (In Russ.) doi:10.15829/1728-8800-2021-2758.

19. Han X, Jiang K, Wang B, et al. Effect of rebamipide on the premalignant progression of chronic gastritis: a randomized controlled study. Clin Drug Investig. 2015; 35(10):665-73. doi:10.1007/s40261-015-0329-z.

20. Kamada T, Sato M, Tokutomi T, et al. Rebamipide improves chronic inflammation in the lesser curvature of the corpus after Helicobacter pylori eradication: a multicenter study. Biomed Res Int. 2015;2015:865146-86514. doi:10.1155/2015/865146.

21. Simadibrata M, Syam A, Rani A, et al. Anti free radical & anti inflammatory effect of rebamipide in chronic gastritis. Open Journal of Gastroenterology. 2013;3:72-7. doi:10.4236/ojgas.2013.31011.

22. Lee JS, Jeon SW, Lee HS, et al. Rebamipide for the Improvement of Gastric Atrophy and Intestinal Metaplasia: A Prospective, Randomized, Pilot Study. Dig Dis Sci. 2022;67(6):2395-402. doi:10.1007/s10620-021-07038-7.

23. Seo GH, Lee H.Chemopreventive Effect of Rebamipide against Gastric Cancer in Patients who undergo Endoscopic Resection for Early Gastric Neoplasms: A Nationwide Claims Study. Digestion. 2019;100(4):221-8. doi:10.1159/000495288.

24. Zhao G, Xue M, Hu Y, et al. How commonly is the diagnosis of gastric low grade dysplasia upgraded following endoscopic resection? A meta-analysis. PLoSOne. 2015;10(7):e0132699. doi:10.1371/journal.pone.0132699.